Medical Device Test Report Review for Submissions

A medical device test report review is not a formatting exercise completed after testing is finished. It is a technical and regulatory assessment of whether the report can credibly support a design verification record, risk management file, premarket submission, or customer quality requirement. A report may contain passing results and still create regulatory questions if the tested configuration, method, acceptance criteria, or data traceability is unclear.

For manufacturers, the review should begin before a report is issued. Clear protocol expectations, sample identification, applicable standards, and acceptance criteria reduce the risk of late-stage revisions that affect submission timelines. Once final data are available, a disciplined review confirms that the report tells an accurate, complete, and defensible story about the device tested.

Why Test Report Review Affects Regulatory Readiness

Regulators and notified bodies do not evaluate a test result in isolation. They assess whether the result is applicable to the device being placed on the market and whether the work was conducted using an appropriate method under controlled conditions. The report is the record connecting the product, the standard, the test laboratory, the raw observations, and the conclusion.

This connection matters when reviewing electrical safety, electromagnetic compatibility, acoustic output, ultrasound image quality, biocompatibility-related material data, endoscope performance, or physiotherapy system evaluation. Each discipline has different technical controls, but the documentation questions are consistent: What was tested? Against which requirement? Using what equipment and procedure? What occurred during testing? Does the conclusion follow from the data?

A thorough review is also a practical way to identify gaps before they become submission deficiencies. If a report does not identify software version, probe model, accessory, firmware configuration, or test article serial number, it may be difficult to demonstrate that the result applies to the commercial device configuration. If deviations are not explained, a reviewer cannot readily determine whether the stated standard was fully applied.

Core Elements of a Medical Device Test Report Review

The appropriate depth of review depends on device risk, intended use, submission pathway, standard complexity, and the role of the report within the overall evidence package. A bench test supporting an internal engineering decision may need less formal scrutiny than a report cited in a 510(k), De Novo request, PMA, technical documentation file, or certification program.

Confirm the Test Article and Configuration

The report should identify the device and all relevant tested components with enough specificity to establish applicability. This commonly includes model number, serial number, revision level, software or firmware version, accessories, cables, transducers, patient-contacting materials, and operating modes.

Configuration control is especially significant for systems with multiple modes or interchangeable components. An ultrasound platform may have different acoustic output characteristics by transducer and preset. A patient monitor may rely on specific leads, power supplies, or communication accessories. A report that broadly names the product family without documenting the actual test configuration can overstate the scope of evidence.

Reviewers should compare report identifiers against design history, bill of materials, labeling, risk documentation, and the configuration intended for commercialization. Differences are not automatically unacceptable, but they require a documented technical rationale. A bridging assessment may be appropriate when changes do not affect the tested characteristics. When changes are material, additional testing may be necessary.

Verify the Standard, Edition, and Acceptance Criteria

The cited standard must match the regulatory strategy and the product’s intended use. Review the full reference, including edition, amendment, collateral standard, particular standard, and any national deviations that apply. A test report referencing a superseded edition is not necessarily unusable, but the manufacturer should understand whether a gap assessment is needed.

Acceptance criteria should be stated clearly and traced to the governing requirement, protocol, specification, or justified engineering limit. A conclusion of “pass” has limited value when the reader cannot determine the criterion applied. For electrical testing, this may involve leakage current, dielectric strength, protective earth continuity, or temperature limits. For acoustic or ultrasound testing, it may involve output parameters, measurement uncertainty, transducer conditions, or image-quality metrics.

Where a standard allows options, test conditions must show which option was selected and why it is applicable. This is particularly relevant when standards define multiple classifications, operating modes, loading conditions, or environmental conditions. A technically correct result under the wrong option does not provide the intended compliance evidence.

Assess Method Execution and Equipment Traceability

A report should describe the method in sufficient detail to show that the applicable test procedure was followed. The level of detail varies by test, but it should establish test setup, environmental conditions where relevant, measurement locations, operating parameters, sample conditioning, and number of samples evaluated.

Equipment used for measurement should be identifiable and within its calibration interval. For measurements with significant uncertainty, the report should state uncertainty or otherwise address its effect on the result when required by the method or laboratory procedure. This is not merely an accreditation formality. A marginal result close to an acceptance limit may require a decision rule or additional technical evaluation.

Testing performed by an ISO/IEC 17025-accredited laboratory provides added confidence in laboratory competence and quality controls, but accreditation status alone does not establish report adequacy. The specific method, scope of accreditation, device configuration, and stated conclusion still need review. Where FDA ASCA-recognized testing is relevant to the submission strategy, manufacturers should also confirm that the test and standard are within the applicable program scope.

Review Results, Deviations, and Conclusions Together

The conclusion must reflect the actual results, including any failures, anomalies, retests, exclusions, or deviations. A report should not bury relevant observations in an appendix while presenting an unqualified compliance statement on the first page.

Particular attention should be paid to deviations from a standard, protocol, or normal test sequence. A deviation is not inherently disqualifying. Some deviations improve relevance to a specific device, address a justified test limitation, or are necessary because of device design. The record should explain what changed, why it changed, who approved it, and whether it affects validity of the result.

Retesting deserves similar scrutiny. If a device was retested after an initial failure, the report should distinguish the original result from the subsequent result and identify any corrective action or configuration change. A final passing outcome may be valid, but only if the tested final configuration is clear and the development record supports the disposition of earlier results.

Questions That Often Reveal Documentation Gaps

During review, the following questions can expose issues that are easy to miss when teams focus only on the pass or fail statement:

• Is the tested device identical to, or scientifically bridged to, the final commercial configuration?
• Are every applicable mode, accessory, probe, cable, and worst-case condition addressed?
• Does each reported result trace to a defined requirement and acceptance criterion?
• Are deviations, anomalies, retests, and exclusions visible and technically justified?
• Do the dates, signatures, approvals, and report revisions support document control requirements?

These questions should be answered using the report and the broader verification evidence package. A laboratory report is one component of compliance evidence, not a substitute for manufacturer responsibility under design controls and risk management.

Establish a Review Process Before Testing Begins

The most efficient report reviews are planned at the quotation and protocol stage. Manufacturers should provide the laboratory with current device descriptions, intended use, applicable standards, desired configurations, accessory lists, and known worst-case conditions. Regulatory and engineering teams should agree on what the report must demonstrate before samples are shipped.

A pre-test discussion is especially useful when the device has complex software states, multiple energy-delivery settings, unusual patient interfaces, or a standard with optional clauses. It allows the laboratory and manufacturer to resolve assumptions early rather than interpreting test coverage after final issuance.

Before approving the final report, quality and regulatory reviewers should verify that document identifiers align with controlled internal records and that the report can be cited consistently in a submission. Engineering should assess whether the technical setup represents the intended use and worst-case rationale. This shared review reduces the common disconnect in which a report is technically valid but poorly aligned to the regulatory claim it is expected to support.

Sigma Scientific Services applies this documentation-focused approach across specialized medical device safety and performance testing, with testing planned around applicable ISO and IEC requirements, defined configurations, and reportable evidence.

A well-reviewed report does more than state that a device met a limit. It gives the manufacturer a clear, traceable basis for explaining why the result applies to the product and why a regulator, auditor, or customer can rely on it.